SBE-β-CD
(Synonyms: Sulfobutylether-β-Cyclodextrin)
166 Cited Publications
Avis client
Based on 166 publication(s) in Google Scholar
SBE-β-CD is a sulfobutylether β-cyclodextrin derivative used as an excipient or a formulating agent to increase the solubility of poorly soluble agents.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.89%
- CAS No.: 182410-00-0
- Masse moléculaire:2083-2257
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Size
Prix
Stock
Quantité
Amount: USD 0.00
Please select quantity
or
or
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Protocole
- Pureté et documentation
- Références
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) SBE-β-CD
More- Nature. 2026 Mar;651(8104):231-241. [Abstract]
- Nature. 2025 Jan;637(8044):184-194. [Abstract]
- Cancer Cell. 2020 Dec 14;38(6):844-856.e7. [Abstract]
- Nat Med. 2017 Jun;23(6):723-732. [Abstract]
- Cell. 2021 Jul 22;184(15):4032-4047.e31. [Abstract]
- Immunity. 2026 May 12;59(5):1398-1421.e20. [Abstract]
- Immunity. 2025 May 22:S1074-7613(25)00221-3. [Abstract]
- Cancer Discov. 2025 Jan 13;15(1):162-178. [Abstract]
- Nat Immunol. 2026 Jan;27(1):110-125. [Abstract]
- Cell Stem Cell. 2024 Oct 3;31(10):1484-1500.e9. [Abstract]
- Cancer Res. 2017 Jan 15;77(2):579-589. [Abstract]
- Nat Microbiol. 2026 Jun;11(6):1677-1695. [Abstract]
- Nat Commun. 2026 Feb 25;17(1):3142. [Abstract]
- Nat Commun. 2025 Sep 17;16(1):8287. [Abstract]
- Nat Commun. 2024 Oct 8;15(1):8723. [Abstract]
- Nat Commun. 2024 Mar 16;15(1):2377. [Abstract]
- Nat Commun. 2024 Feb 14;15(1):1353. [Abstract]
- Nat Commun. 2023 Oct 18;14(1):6584. [Abstract]
- Nat Commun. 2019 Jul 1;10(1):2901. [Abstract]
- Nat Commun. 2018 Jun 29;9(1):2547. [Abstract]
- Metabolism. 2018 May:82:88-99. [Abstract]
- Sci Transl Med. 2021 Jan 20;13(577):eaba7401. [Abstract]
- Theranostics. 2022 May 27;12(10):4581-4598. [Abstract]
- Theranostics. 2019 Nov 26;9(26):8426-8436. [Abstract]
- J Clin Invest. 2025 Jun 2;135(11):e187490. [Abstract]
- J Exp Clin Cancer Res. 2024 Jul 24;43(1):205. [Abstract]
- J Exp Clin Cancer Res. 2021 Mar 26;40(1):113. [Abstract]
- Adv Sci (Weinh). 2026 Jun;13(34):e22891. [Abstract]
- Adv Sci (Weinh). 2025 Oct 5:e03576. [Abstract]
- Adv Sci (Weinh). 2025 Aug;12(32):e04467. [Abstract]
- Adv Sci (Weinh). 2025 Apr;12(13):e2417449. [Abstract]
- Adv Sci (Weinh). 2023 Jan;10(3):e2203718. [Abstract]
- Alzheimers Dement. 2025 Feb;21(2):e14518. [Abstract]
- Chem Eng J. 2025 Oct 8;524:169421.
- Cancer Lett. 2016 Oct 10;381(1):14-22. [Abstract]
- Phytomedicine. 2025 Sep:145:156951. [Abstract]
- Acta Pharmacol Sin. 2026 Jan 1. [Abstract]
- Cell Death Discov. 2021 Dec 4;7(1):374. [Abstract]
- Proc Natl Acad Sci U S A. 2025 Mar 25;122(12):e2426107122. [Abstract]
- BME Front. 2025 Dec 9:6:0207. [Abstract]
- Int J Biol Macromol. 2025 Jul 29;321(Pt 3):146394. [Abstract]
- Int J Nanomedicine. 2025 Jan 16:20:669-684. [Abstract]
- Int J Biol Macromol. 2024 Oct;277(Pt 1):134024. [Abstract]
- Mol Ther Oncol. 2025 Dec 9.
- Mol Med. 2026 Feb 28;32(1):32. [Abstract]
- Mol Med. 2025 Jun 11;31(1):234. [Abstract]
- Phytother Res. 2023 Feb;37(2):611-626. [Abstract]
- Cancer Immunol Res. 2026 May 28. [Abstract]
- Cancer Immunol Res. 2021 Jun;9(6):665-681. [Abstract]
- Br J Cancer. 2022 Sep;127(4):661-674. [Abstract]
- Cell Rep. 2025 Nov 18;44(12):116577. [Abstract]
- Cell Rep. 2023 Apr 15;42(4):112396. [Abstract]
- Cell Rep. 2020 Nov 17;33(7):108395. [Abstract]
- Cell Rep. 2019 Oct 8;29(2):249-257.e8. [Abstract]
- Cell Prolif. 2024 Dec;57(12):e13719. [Abstract]
- Transl Psychiatry. 2023 Oct 6;13(1):310. [Abstract]
- Br J Pharmacol. 2018 Jan;175(1):84-99. [Abstract]
- Cell Mol Neurobiol. 2026 Jun 19. [Abstract]
- Int J Radiat Oncol Biol Phys. 2025 Jun 16:S0360-3016(25)03903-3. [Abstract]
- Int J Oncol. 2017 Aug;51(2):425-434. [Abstract]
- Pharmaceutics. 2026 Jan 12;18(1):103. [Abstract]
- Pharmaceutics. 2025 Nov 27;17(12):1524. [Abstract]
- J Ethnopharmacol. 2026 Jun 24:371:122040. [Abstract]
- Ecotoxicol Environ Saf. 2024 Oct 1:284:116906. [Abstract]
- Cell Biosci. 2025 Apr 13;15(1):46. [Abstract]
- Mol Ther Nucleic Acids. 2022 Jul 20:29:538-549. [Abstract]
- Cell Mol Life Sci. 2021 Feb;78(4):1837-1851. [Abstract]
- Life Sci. 2025 Oct 15:379:123849. [Abstract]
- Life Sci. 2025 Aug 15:375:123744. [Abstract]
- RSC Adv. 2023 Sep 11;13(39):27244-27254. [Abstract]
- Neurobiol Dis. 2025 Sep:213:107020. [Abstract]
- Neurobiol Dis. 2022 Jun 15:168:105689. [Abstract]
- J Am Heart Assoc. 2021 Jul 20;10(14):e019877. [Abstract]
- Matrix Biol. 2023 Apr:118:69-91. [Abstract]
- Matrix Biol. 2022 Sep:112:171-189. [Abstract]
- Eur J Pharmacol. 2025 Mar 15:991:177329. [Abstract]
- J Affect Disord. 2024 Apr 1:350:761-773. [Abstract]
- Int Immunopharmacol. 2025 Oct 30:164:115384. [Abstract]
- Int Immunopharmacol. 2025 Jun 5:157:114796. [Abstract]
- Int Immunopharmacol. 2025 Mar 26:150:114278. [Abstract]
- Mol Neurobiol. 2025 Jan;62(1):1079-1093. [Abstract]
- Mucosal Immunol. 2021 Mar;14(2):500-510. [Abstract]
- Inflammation. 2025 Mar 1. [Abstract]
- Front Pharmacol. 2022 Jan 10;12:792263. [Abstract]
- Front Pharmacol. 2018 Jan 30:9:25. [Abstract]
- J Ovarian Res. 2023 Nov 28;16(1):231. [Abstract]
- ACS Omega. 2025 Dec 23.
- Molecules. 2023 May 15;28(10):4096. [Abstract]
- Sci Rep. 2026 May 4;16(1):20485. [Abstract]
- Sci Rep. 2026 Apr 20;16(1):12890. [Abstract]
- Sci Rep. 2023 May 11;13(1):7656. [Abstract]
- Cancer Sci. 2016 May;107(5):638-43. [Abstract]
- Int J Cancer. 2016 Feb 15;138(4):1024-32. [Abstract]
- Sci Rep. 2015 Oct 30:5:15881. [Abstract]
- Neuropharmacology. 2026 May 1:288:110833. [Abstract]
- Oncol Rep. 2019 Jan;41(1):447-454. [Abstract]
- J Neurochem. 2026 Jan;170(1):e70336. [Abstract]
- Acta Biochim Biophys Sin (Shanghai). 2026 Jul 13. [Abstract]
- iScience. 2025 Nov 19;28(12):114120. [Abstract]
- Neurochem Res. 2022 Dec;47(12):3777-3791. [Abstract]
- Lung. 2024 Nov 27;203(1):4. [Abstract]
- J Biol Chem. 2024 Nov;300(11):107848. [Abstract]
- Mol Immunol. 2026 Jul:195:186-197. [Abstract]
- Mol Immunol. 2022 Dec:152:55-66. [Abstract]
- PLoS Negl Trop Dis. 2017 Dec 28;11(12):e0006104. [Abstract]
- ChemMedChem. 2026 Mar 13;21(5):e202500744. [Abstract]
- BMC Pharmacol Toxicol. 2025 Jul 17;26(1):134. [Abstract]
- Cancer Prev Res. 2024 Oct 1;17(10):457-470. [Abstract]
- Comput Biol Chem. 2024 Oct:112:108111. [Abstract]
- Neuroscience. 2023 Sep 15:528:64-74. [Abstract]
- Cell Immunol. 2021 Aug:366:104384. [Abstract]
- Neuropsychiatr Dis Treat. 2022 May 16:18:1027-1037. [Abstract]
- J Pain Res. 2026 Jun 3:19:604818. [Abstract]
- Cereb Cortex. 2023 Jul 5;33(14):8858-8875. [Abstract]
- PeerJ. 2026 Apr 30:14:e21194. [Abstract]
- PLoS One. 2025 Feb 5;20(2):e0316952. [Abstract]
- PLoS One. 2024 Sep 19;19(9):e0310524. [Abstract]
- PLoS One. 2023 Sep 14;18(9):e0291537. [Abstract]
- Physiol Behav. 2025 Nov 1:301:115059. [Abstract]
- Clin Exp Pharmacol Physiol. 2025 Nov;52(11):e70072. [Abstract]
- Biochem Biophys Res Commun. 2018 Jun 18;501(1):9-15. [Abstract]
- Cancer Chemother Pharmacol. 2016 Mar;77(3):623-8. [Abstract]
- Biochem Biophys Res Commun. 2015 May 1;460(2):362-7. [Abstract]
- Biopharm Drug Dispos. 2018 Jan;39(1):30-37. [Abstract]
- Oncol Lett. 2024 Sep 24;28(6):560. [Abstract]
- Oncol Lett. 2017 Dec;14(6):6863-6868. [Abstract]
- Hematology. 2026 Dec 31;31(1):2691533. [Abstract]
- World Neurosurg. 2022 Feb:158:e856-e864. [Abstract]
- SSRN. 2026 Jun 23.
- medRxiv. 2026 May 6:2026.05.05.26352474. [Abstract]
- SSRN. 2026 May 21.
- bioRxiv. 2026 May 21:2026.05.19.726175. [Abstract]
- bioRxiv. 2026 Apr 8:2026.04.05.713683. [Abstract]
- bioRxiv. 2026 Mar 30:2026.03.26.714605. [Abstract]
- bioRxiv. 2026 Mar 6.
- J Mol Liq. 2026 Feb 15.
- bioRxiv. 2025 Oct 6.
- bioRxiv. 2025 Sep 3:2025.08.30.673282. [Abstract]
- ALA-Porphyrin Science. 2025.
- bioRxiv. 2025 Jun 12:2025.06.10.656791. [Abstract]
- Patent. US20250144040A1.
- bioRxiv. 2025 March 14.
- Guidelines and Standards in Chinese Medicine. 2024 Dec.
- Res Sq. 2024 Jul 12.
- SSRN. 2024 Jun 19.
- biorxiv. 2024 Jun 05.
- bioRxiv. 2024 Jun 28:2024.06.23.600305. [Abstract]
- bioRxiv. 2024 Apr 12.
- bioRxiv. 2024 Mar 25:2024.03.21.586157. [Abstract]
- Res Sq. 2024 Feb 22:rs.3.rs-3959342. [Abstract]
- bioRxiv. 2023 Oct 1:2023.09.29.560194. [Abstract]
- bioRxiv. 2023 Oct 10.
- bioRxiv. 2023 Sep 16:2023.09.15.554413. [Abstract]
- Research Square Preprint. 2023 Sep 18.
- University of Ottawa. 2023 Jun 12.
- Oxid Med Cell Longev. 2022 Dec 7:2022:3373828. [Abstract]
- Patent. US20220380473A1.
- J Mol Liq. 9 September 2022, 120314.
- Research Square Print. 2022 Jun.
- Research Square Preprint. 2022 May.
- Patent. US20220002420A1.
- University of Cambridge. 2021 , e20.
- ETH Zurich. 2021 Apr.
- Patent. US20200385396A1.
- Patent. US20170290918A1.
- University of Chile. 2017.
Activité biologique
Description
SBE-β-CD is a sulfobutylether β-cyclodextrin derivative used as an excipient or a formulating agent to increase the solubility of poorly soluble agents[1].
In Vitro
SBE-β-CD is a chemically modified β-CD that is a cyclic hydrophilic oligosaccharide which is negatively charged in aqueous media. β-CD functioned is a solubilizer only at low concentrations, whereas SBE7-β-CD exhibits strong solubilizing effects over a wide concentration range[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
20% SBE-β-CD in saline:
Guidelines (Following is our recommended protocol. This protocol only provides a guideline, and should be modified according to your specific needs).
1. Dissolve 0.9 g of NaCl in 100 mL distilled water to make a clear 0.9% saline solution.
2. Measure 2 g of dry SBE-β-CD.
3. Dissolve 2 g of SBE-β-CD in 0.9% saline to make 10 mL with a 20% (w/v) concentration. These may require ultrasonic (20-40 kHz, 30 seconds, repeat 3 times) or heating (37°C for about 30 minutes). If precipitation is observed, the precipitates can be dissolved by heating to 37°C and vortexing before use.
Guidelines (Following is our recommended protocol. This protocol only provides a guideline, and should be modified according to your specific needs).
1. Dissolve 0.9 g of NaCl in 100 mL distilled water to make a clear 0.9% saline solution.
2. Measure 2 g of dry SBE-β-CD.
3. Dissolve 2 g of SBE-β-CD in 0.9% saline to make 10 mL with a 20% (w/v) concentration. These may require ultrasonic (20-40 kHz, 30 seconds, repeat 3 times) or heating (37°C for about 30 minutes). If precipitation is observed, the precipitates can be dissolved by heating to 37°C and vortexing before use.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 182410-00-0
-
Appearance Solid
-
Masse moléculaire 2083-2257
-
Color White to off-white
-
SMILES
[R]O[C@@H]1[C@H](O[R])[C@H](O[C@@H]2[C@H](O[R])C(O[R])[C@H](O3)[C@@H](CO[R])O2)[C@@H](CO[R])O[C@@H]1O[C@H]4[C@H](O[R])[C@@H](O[R])[C@@H](O[C@H]5[C@H](O[R])[C@@H](O[R])[C@@H](O[C@@H]6C(O[R])[C@H](O[R])[C@H](O[C@@H]7[C@@H](O[R])[C@H](O[R])[C@H](O[C@@H]8[C@@H](O[R])[C@H](O[R])[C@H]3O[C@H]8CO[R])O[C@H]7CO[R])O[C@H]6CO[R])O[C@@H]5CO[R])O[C@@H]4CO[R].[R= H 21-m or C4H8SO3-Na+ m , m=6.0-7.1]
-
Synonyms
Sulfobutylether-β-Cyclodextrin
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (166)
All
Journal Impact Factor
-
Journal Impact Factor
-
Most Recent
-
Nature
2026 Mar;651(8104):231-241. PMID: 41565826 -
Nature
2025 Jan;637(8044):184-194. PMID: 39633048 -
Cancer Cell
Elevated CXorf67 Expression in PFA Ependymomas Suppresses DNA Repair and Sensitizes to PARP Inhibitors. [Abstract]2020 Dec 14;38(6):844-856.e7. PMID: 33186520 -
Nat Med
MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1. [Abstract]2017 Jun;23(6):723-732. PMID: 28394332 -
Cell
2021 Jul 22;184(15):4032-4047.e31. PMID: 34171309 -
Immunity
2026 May 12;59(5):1398-1421.e20. PMID: 41956098 -
Immunity
Nociceptor neurons suppress alveolar macrophage-induced Siglec-F+ neutrophil-mediated inflammation to protect against pulmonary fibrosis. [Abstract]2025 May 22:S1074-7613(25)00221-3. PMID: 40449484 -
Cancer Discov
Combined KRAS Inhibition and Immune Therapy Generates Durable Complete Responses in an Autochthonous PDAC Model. [Abstract]2025 Jan 13;15(1):162-178. PMID: 39348506 -
Nat Immunol
Tissue-resident exhausted and memory CD8+ T cells have distinct ontogeny, function and role in disease. [Abstract]2026 Jan;27(1):110-125. PMID: 41461986 -
Cell Stem Cell
Mitochondrial serine catabolism safeguards maintenance of the hematopoietic stem cell pool in homeostasis and injury. [Abstract]2024 Oct 3;31(10):1484-1500.e9. PMID: 39181130 -
Cancer Res
SPINK6 Promotes Metastasis of Nasopharyngeal Carcinoma via Binding and Activation of Epithelial Growth Factor Receptor. [Abstract]2017 Jan 15;77(2):579-589. PMID: 27671677 -
Nat Microbiol
Lipid accumulation in tuberculosis granulomas inhibits macrophage-CD4+ T cell interactions and infection control. [Abstract]2026 Jun;11(6):1677-1695. PMID: 41933199 -
Nat Commun
Targeting de novo pyrimidine synthesis confers vulnerability to copper-mediated ATR inactivation in PARP inhibitor-resistant ovarian cancer. [Abstract]2026 Feb 25;17(1):3142. PMID: 41735312 -
Nat Commun
RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticity. [Abstract]2025 Sep 17;16(1):8287. PMID: 40962798 -
Nat Commun
A germline-to-soma signal triggers an age-related decline of mitochondrial stress response. [Abstract]2024 Oct 8;15(1):8723. PMID: 39379393 -
Nat Commun
2024 Mar 16;15(1):2377. PMID: 38493213 -
Nat Commun
Multigenerational paternal obesity enhances the susceptibility to male subfertility in offspring via Wt1 N6-methyladenosine modification. [Abstract]2024 Feb 14;15(1):1353. PMID: 38355624 -
Nat Commun
Gut insulin action protects from hepatocarcinogenesis in diabetic mice comorbid with nonalcoholic steatohepatitis. [Abstract]2023 Oct 18;14(1):6584. PMID: 37852976 -
Nat Commun
An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis. [Abstract]2019 Jul 1;10(1):2901. PMID: 31263101 -
Nat Commun
Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program. [Abstract]2018 Jun 29;9(1):2547. PMID: 29959321 -
Metabolism
Anti-apoptotic activity of human matrix metalloproteinase-2 attenuates diabetes mellitus. [Abstract]2018 May:82:88-99. PMID: 29366755 -
Sci Transl Med
Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma. [Abstract]2021 Jan 20;13(577):eaba7401. PMID: 33472956 -
Theranostics
Promising alternatives of CD47 monoclonal antibody: an injectable degradable hydrogel loaded with PQ912 for postoperative immunotherapy effectively blocks CD47-SIRPα signal. [Abstract]2022 May 27;12(10):4581-4598. PMID: 35832081 -
Theranostics
Development of Adamantane-Conjugated TLR7/8 Agonists for Supramolecular Delivery and Cancer Immunotherapy. [Abstract]2019 Nov 26;9(26):8426-8436. PMID: 31879528 -
J Clin Invest
2025 Jun 2;135(11):e187490. PMID: 40454483 -
J Exp Clin Cancer Res
Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia. [Abstract]2024 Jul 24;43(1):205. PMID: 39044280 -
J Exp Clin Cancer Res
Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma. [Abstract]2021 Mar 26;40(1):113. PMID: 33771199 -
Adv Sci (Weinh)
SAA/FPR2 Signaling Between Pericentral Hepatocytes and Macrophages Exacerbates Zonated Liver Transplant Injury. [Abstract]2026 Jun;13(34):e22891. PMID: 41904943 -
Adv Sci (Weinh)
2025 Oct 5:e03576. PMID: 41047470 -
Adv Sci (Weinh)
A Novel Cranial Bone Transport Technique Repairs Skull Defect and Minimizes Brain Injury Outcome in Traumatic Brain Injury Rats. [Abstract]2025 Aug;12(32):e04467. PMID: 40448603 -
Adv Sci (Weinh)
Hybrid Electro-optical Stimulation Improves Ischemic Brain Damage by Augmenting the Glymphatic System. [Abstract]2025 Apr;12(13):e2417449. PMID: 39927473 -
Adv Sci (Weinh)
STING Suppresses Mitochondrial VDAC2 to Govern RCC Growth Independent of Innate Immunity. [Abstract]2023 Jan;10(3):e2203718. PMID: 36445063 -
Alzheimers Dement
Cranial bone maneuver ameliorates Alzheimer's disease pathology via enhancing meningeal lymphatic drainage function. [Abstract]2025 Feb;21(2):e14518. PMID: 39887820 -
-
Cancer Lett
A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis. [Abstract]2016 Oct 10;381(1):14-22. PMID: 27424523 -
Phytomedicine
Motherwort synergized with oxytocin for postpartum hemorrhage prevention: Integrated clinical efficacy and mechanism exploration. [Abstract]2025 Sep:145:156951. PMID: 40527062 -
Acta Pharmacol Sin
A FAPI-based small-molecule drug conjugate alleviates rheumatoid arthritis by targeting pathogenic FAPα-expressing fibroblasts. [Abstract]2026 Jan 1. PMID: 41478880 -
Cell Death Discov
Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis. [Abstract]2021 Dec 4;7(1):374. PMID: 34864819 -
Proc Natl Acad Sci U S A
Androgen receptors in corticotropin-releasing hormone neurons mediate the sexual dimorphism in restraint-induced thymic atrophy. [Abstract]2025 Mar 25;122(12):e2426107122. PMID: 40106355 -
BME Front
Quantifying Spatiotemporal Heterogeneity of Tumor Metabolism and Vasculature with a Multiparametric Point-of-Investigation Microscope. [Abstract]2025 Dec 9:6:0207. PMID: 41377143 -
Int J Biol Macromol
Exploiting an evolutionary constraint: Targeting TatD nuclease with chrysosplenol D disrupts Mycoplasma gallisepticum infection. [Abstract]2025 Jul 29;321(Pt 3):146394. PMID: 40744178 -
Int J Nanomedicine
Viral Mimetic Bacterial Outer Membrane Vesicles for Targeting Angiotensin-Converting Enzyme 2. [Abstract]2025 Jan 16:20:669-684. PMID: 39835181 -
Int J Biol Macromol
Jun and JunB members of the AP-1 complex are potential therapeutic targets for silicosis. [Abstract]2024 Oct;277(Pt 1):134024. PMID: 39032899 -
-
Mol Med
Correction: Bavachin ameliorates cisplatin-induced nephrotoxicity by enhancing mitochondrial β-oxidation and lipid metabolism through MFN2. [Abstract]2026 Feb 28;32(1):32. PMID: 41764431 -
Mol Med
Bavachin ameliorates cisplatin-induced nephrotoxicity by enhancing mitochondrial β-oxidation and lipid metabolism through MFN2. [Abstract]2025 Jun 11;31(1):234. PMID: 40500698 -
Phytother Res
Increasing brain glucose uptake by Gypenoside LXXV ameliorates cognitive deficits in a mouse model of diabetic Alzheimer's disease. [Abstract]2023 Feb;37(2):611-626. PMID: 36325883 -
Cancer Immunol Res
Targeting CCR1 remodels the tumor microenvironment and relieves immune suppression in pancreatic cancer. [Abstract]2026 May 28. PMID: 42207977 -
Cancer Immunol Res
Chemotherapy Induces Tumor-Associated Macrophages that Aid Adaptive Immune Responses in Ovarian Cancer. [Abstract]2021 Jun;9(6):665-681. PMID: 33839687 -
Br J Cancer
Targeting epidermal growth factor receptor in paclitaxel-resistant human breast and lung cancer cells with upregulated glucose-6-phosphate dehydrogenase. [Abstract]2022 Sep;127(4):661-674. PMID: 35597872 -
Cell Rep
Blocking glycogen synthase 1 in white adipose tissue alleviates hypermetabolism following severe burn injury through inhibition of JAK2 by UDPG. [Abstract]2025 Nov 18;44(12):116577. PMID: 41259203 -
Cell Rep
2023 Apr 15;42(4):112396. PMID: 37061917 -
Cell Rep
Requisite Chromatin Remodeling for Myeloid and Erythroid Lineage Differentiation from Erythromyeloid Progenitors. [Abstract]2020 Nov 17;33(7):108395. PMID: 33207205 -
Cell Rep
2019 Oct 8;29(2):249-257.e8. PMID: 31597089 -
Cell Prolif
Cellular senescence mediates retinal ganglion cell survival regulation post-optic nerve crush injury. [Abstract]2024 Dec;57(12):e13719. PMID: 39021340 -
Transl Psychiatry
Melatonin alleviates depression-like behaviors and cognitive dysfunction in mice by regulating the circadian rhythm of AQP4 polarization. [Abstract]2023 Oct 6;13(1):310. PMID: 37802998 -
Br J Pharmacol
Transient receptor potential vanilloid 4 channel regulates vascular endothelial permeability during colonic inflammation in dextran sulphate sodium-induced murine colitis. [Abstract]2018 Jan;175(1):84-99. PMID: 29053877 -
Cell Mol Neurobiol
Activation of the Reverse Cholesterol Transport Pathway: A Strategy to Ameliorate Lipid Metabolic Dyshomeostasis in the Microenvironment Following Spinal Cord Injury. [Abstract]2026 Jun 19. PMID: 42321551 -
Int J Radiat Oncol Biol Phys
2025 Jun 16:S0360-3016(25)03903-3. PMID: 40532892 -
Int J Oncol
Bevacizumab counteracts VEGF-dependent resistance to erlotinib in an EGFR-mutated NSCLC xenograft model. [Abstract]2017 Aug;51(2):425-434. PMID: 28627678 -
Pharmaceutics
The Activity of FDA-Approved Prodrug Isavuconazonium Sulfate and Its Major Metabolite Isavuconazole Against Naegleria fowleri. [Abstract]2026 Jan 12;18(1):103. PMID: 41599210 -
Pharmaceutics
CC-90009, a Cereblon E3 Ligase Modulator, Exhibits Antiviral Efficacy Against JEV In Vitro and In Vivo via Targeted Degradation of GSPT1 and Viral NS5 Protein. [Abstract]2025 Nov 27;17(12):1524. PMID: 41471039 -
J Ethnopharmacol
Liquiritin prevents preterm labor by remodeling decidual steroid homeostasis through 11β-HSD1 inhibition. [Abstract]2026 Jun 24:371:122040. PMID: 42341859 -
Ecotoxicol Environ Saf
Calcitriol alleviates noise-induced hearing loss by regulating the ATF3/DUSP1 signalling pathway. [Abstract]2024 Oct 1:284:116906. PMID: 39182283 -
Cell Biosci
The RBM39 degrader indisulam inhibits acute megakaryoblastic leukemia by altering the alternative splicing of ZMYND8. [Abstract]2025 Apr 13;15(1):46. PMID: 40223119 -
Mol Ther Nucleic Acids
2022 Jul 20:29:538-549. PMID: 36035756 -
Cell Mol Life Sci
Novel carfilzomib-based combinations as potential therapeutic strategies for liposarcomas. [Abstract]2021 Feb;78(4):1837-1851. PMID: 32851475 -
Life Sci
CXCL10 modulates airway inflammation in asthma via Sirt3-dependent macrophage homeostasis. [Abstract]2025 Oct 15:379:123849. PMID: 40651693 -
Life Sci
Glucocorticoid reduces mortality in LPS-induced sepsis mouse model by inhibiting JAK1/STAT3-mediated inflammatory response and restoring tricarboxylic acid cycle. [Abstract]2025 Aug 15:375:123744. PMID: 40408938 -
RSC Adv
Enhancing solubility and stability of sorafenib through cyclodextrin-based inclusion complexation: in silico and in vitro studies. [Abstract]2023 Sep 11;13(39):27244-27254. PMID: 37701271 -
Neurobiol Dis
Nuclear localization of platelet activating factor receptor accounts for microglial phagocytosis in ischemic stroke. [Abstract]2025 Sep:213:107020. PMID: 40623479 -
Neurobiol Dis
P2X7-dependent constitutive Interleukin-1β release from pyramidal neurons of the normal mouse hippocampus: Evidence for a role in maintenance of the innate seizure threshold. [Abstract]2022 Jun 15:168:105689. PMID: 35288304 -
J Am Heart Assoc
Prohibitin-1 Is a Dynamically Regulated Blood Protein With Cardioprotective Effects in Sepsis. [Abstract]2021 Jul 20;10(14):e019877. PMID: 34219469 -
Matrix Biol
Delayed inhibition of collagen deposition by targeting bone morphogenetic protein 1 promotes recovery after spinal cord injury. [Abstract]2023 Apr:118:69-91. PMID: 36918086 -
Matrix Biol
2022 Sep:112:171-189. PMID: 36031013 -
Eur J Pharmacol
GW4064 inhibits migration and invasion in human glioblastoma multiforme through the downregulation of PKCα. [Abstract]2025 Mar 15:991:177329. PMID: 39900326 -
J Affect Disord
Roflumilast: Modulating neuroinflammation and improving motor function and depressive symptoms in multiple sclerosis. [Abstract]2024 Apr 1:350:761-773. PMID: 38220100 -
Int Immunopharmacol
Lactylation of MYH9 and its impact on FOXO3a/Bim signaling in sepsis-induced gut-vascular barrier injury. [Abstract]2025 Oct 30:164:115384. PMID: 40850198 -
Int Immunopharmacol
OPTN ameliorates chondrocyte apoptosis in temporomandibular joint osteoarthritis by modulating ER-mitochondria Ca2+ transfer. [Abstract]2025 Jun 5:157:114796. PMID: 40339496 -
Int Immunopharmacol
Prexasertib exerts a synergistic effect on the antitumor activity of Lenvatinib through ALOX15-mediated ferroptosis in hepatocellular carcinoma. [Abstract]2025 Mar 26:150:114278. PMID: 39954659 -
Mol Neurobiol
2025 Jan;62(1):1079-1093. PMID: 38958889 -
Mucosal Immunol
Obeticholic acid ameliorates severity of Clostridioides difficile infection in high fat diet-induced obese mice. [Abstract]2021 Mar;14(2):500-510. PMID: 32811993 -
Inflammation
Inhibition of Cullin3 Neddylation Alleviates Diabetic Retinopathy by Activating Nrf2 Signaling to Combat ROS-Induced Oxidative Stress and Inflammation. [Abstract]2025 Mar 1. PMID: 40021543 -
Front Pharmacol
Hsp47 Inhibitor Col003 Attenuates Collagen-Induced Platelet Activation and Cerebral Ischemic-Reperfusion Injury in Rats. [Abstract]2022 Jan 10;12:792263. PMID: 35082674 -
Front Pharmacol
15, 16-Dihydrotanshinone I Inhibits Hemangiomas through Inducing Pro-apoptotic and Anti-angiogenic Mechanisms in Vitro and in Vivo. [Abstract]2018 Jan 30:9:25. PMID: 29441017 -
J Ovarian Res
BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy. [Abstract]2023 Nov 28;16(1):231. PMID: 38017453 -
-
Molecules
Characterization of Thymoquinone-Sulfobutylether-β-Cyclodextrin Inclusion Complex for Anticancer Applications. [Abstract]2023 May 15;28(10):4096. PMID: 37241838 -
Sci Rep
BTK promotes neuroinflammation after intracerebral hemorrhage involving hub genes and alterations in microglial functions. [Abstract]2026 May 4;16(1):20485. PMID: 42082621 -
Sci Rep
A degrader of HER2 and EGFR abolishes p95HER2 and shows robust antitumor efficacy in HER2-positive breast cancer. [Abstract]2026 Apr 20;16(1):12890. PMID: 42009845 -
Sci Rep
Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer. [Abstract]2023 May 11;13(1):7656. PMID: 37169953 -
Cancer Sci
Xenotransplantation elicits salient tumorigenicity of adult T-cell leukemia-derived cells via aberrant AKT activation. [Abstract]2016 May;107(5):638-43. PMID: 26928911 -
Int J Cancer
Impact of bevacizumab in combination with erlotinib on EGFR-mutated non-small cell lung cancer xenograft models with T790M mutation or MET amplification. [Abstract]2016 Feb 15;138(4):1024-32. PMID: 26370161 -
Sci Rep
The Akt-mTOR axis is a pivotal regulator of eccentric hypertrophy during volume overload. [Abstract]2015 Oct 30:5:15881. PMID: 26515499 -
Neuropharmacology
Assessing the utility of the neurosteroid zuranolone to modify alcohol-related behaviours. [Abstract]2026 May 1:288:110833. PMID: 41520874 -
Oncol Rep
Non‑invasive monitoring of cisplatin and erlotinib efficacy against lung cancer in orthotopic SCID mouse models by small animal FDG‑PET/CT and CT. [Abstract]2019 Jan;41(1):447-454. PMID: 30365151 -
J Neurochem
Cocaine-Induced Changes in the BRD4 Interactome Identifies Casein Kinase 1 Epsilon as a Therapeutic Target. [Abstract]2026 Jan;170(1):e70336. PMID: 41521463 -
Acta Biochim Biophys Sin (Shanghai)
Ciclopirox suppresses melanoma growth by activating ER stress-driven apoptosis and disrupting Src/STAT3 signaling. [Abstract]2026 Jul 13. PMID: 42441369 -
iScience
2025 Nov 19;28(12):114120. PMID: 41438086 -
Neurochem Res
3BDO Alleviates Seizures and Improves Cognitive Function by Regulating Autophagy in Pentylenetetrazol (PTZ)-Kindled Epileptic Mice Model. [Abstract]2022 Dec;47(12):3777-3791. PMID: 36243819 -
Lung
Disulfiram Alleviates MTX-Induced Pulmonary Fibrosis by Inhibiting EMT in Type 2 Alveolar Epithelial Cells. [Abstract]2024 Nov 27;203(1):4. PMID: 39601871 -
J Biol Chem
Nerve injury augments Cacna2d1 transcription via CK2-mediated phosphorylation of the histone deacetylase HDAC2 in dorsal root ganglia. [Abstract]2024 Nov;300(11):107848. PMID: 39357831 -
Mol Immunol
HSP47 inhibitor Col003 attenuates thromboinflammation after cerebral ischemia-reperfusion by suppressing GPVI-mediated CD84 shedding in platelets. [Abstract]2026 Jul:195:186-197. PMID: 42172863 -
Mol Immunol
The mechanism underlying ICAM-1 and E-selectin-mediated hypertriglyceridemic pancreatitis-associated lung injury. [Abstract]2022 Dec:152:55-66. PMID: 36279659 -
PLoS Negl Trop Dis
CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM). [Abstract]2017 Dec 28;11(12):e0006104. PMID: 29284029 -
ChemMedChem
Advancing Accurate Quantification of Protein-Ligand Interactions: Differential Scanning Calorimetry as a Precision Screening Tool Using BCL-2 as a Model System. [Abstract]2026 Mar 13;21(5):e202500744. PMID: 41774457 -
BMC Pharmacol Toxicol
Dimethyl fumarate attenuates liver injury in a mouse model of cecal ligation and puncture by modulating inflammatory, angiogenic and pyroptotic pathways. [Abstract]2025 Jul 17;26(1):134. PMID: 40676712 -
Cancer Prev Res
Preventive Treatment with a CD73 Small Molecule Inhibitor Enhances Immune Surveillance in K-Ras Mutant Pancreatic Intraepithelial Neoplasia. [Abstract]2024 Oct 1;17(10):457-470. PMID: 39099209 -
Comput Biol Chem
Evaluating solubility, stability, and inclusion complexation of oxyresveratrol with various β-cyclodextrin derivatives using advanced computational techniques and experimental validation. [Abstract]2024 Oct:112:108111. PMID: 38879954 -
Neuroscience
2023 Sep 15:528:64-74. PMID: 37516436 -
Cell Immunol
STING agonist and IDO inhibitor combination therapy inhibits tumor progression in murine models of colorectal cancer. [Abstract]2021 Aug:366:104384. PMID: 34182334 -
Neuropsychiatr Dis Treat
VRT-043198 Ameliorates Surgery-Induced Neurocognitive Disorders by Restoring the NGF and BNDF Expression in Aged Mice. [Abstract]2022 May 16:18:1027-1037. PMID: 35607505 -
J Pain Res
Wrist-Ankle Acupuncture Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Neuronal α7 Nicotinic Acetylcholine Receptor-Dependent Modulation of Spinal Glutamatergic/NMDAR Signaling. [Abstract]2026 Jun 3:19:604818. PMID: 42267150 -
Cereb Cortex
P2X7 receptor-mediated depression-like reactions arising in the mouse medial prefrontal cortex. [Abstract]2023 Jul 5;33(14):8858-8875. PMID: 37183178 -
PeerJ
Androgen promotes oocyte development by upregulating gap junction intercellular communication activity in granulosa cells in mice. [Abstract]2026 Apr 30:14:e21194. PMID: 42083638 -
PLoS One
Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection. [Abstract]2025 Feb 5;20(2):e0316952. PMID: 39908288 -
PLoS One
Berberine potentiates liver inflammation and fibrosis in the PI*Z hAAT transgenic murine model. [Abstract]2024 Sep 19;19(9):e0310524. PMID: 39298444 -
PLoS One
Animal efficacy study of a plant extract complex (BEN815) as a potential treatment for COVID-19. [Abstract]2023 Sep 14;18(9):e0291537. PMID: 37708114 -
Physiol Behav
Acupuncture waggle needling alleviates spastic movement disorder in post-stroke rats via GLT-1 activation to modulate Glu/GABA-Gln cycle. [Abstract]2025 Nov 1:301:115059. PMID: 40783057 -
Clin Exp Pharmacol Physiol
Combination of Tanshinone IIA and Matrine Alleviates Lipopolysaccharide-Induced Acute Lung Injury by Supressing Ferroptosis via Nrf2/HO-1 Pathway Activation. [Abstract]2025 Nov;52(11):e70072. PMID: 41063422 -
Biochem Biophys Res Commun
GSK126 alleviates the obesity phenotype by promoting the differentiation of thermogenic beige adipocytes in diet-induced obese mice. [Abstract]2018 Jun 18;501(1):9-15. PMID: 29654753 -
Cancer Chemother Pharmacol
Antitumor activity of alectinib, a selective ALK inhibitor, in an ALK-positive NSCLC cell line harboring G1269A mutation: Efficacy of alectinib against ALK G1269A mutated cells. [Abstract]2016 Mar;77(3):623-8. PMID: 26849637 -
Biochem Biophys Res Commun
Chronopharmacodynamics and mechanisms of antitumor effect induced by erlotinib in xenograft-bearing nude mice. [Abstract]2015 May 1;460(2):362-7. PMID: 25791480 -
Biopharm Drug Dispos
The possible clinical impact of risperidone on P-glycoprotein-mediated transport of tacrolimus: A case report and in vitro study. [Abstract]2018 Jan;39(1):30-37. PMID: 29055041 -
Oncol Lett
Therapeutic effects of paeonol on non‑small cell lung cancer cells via regulation of the MAPK pathway. [Abstract]2024 Sep 24;28(6):560. PMID: 39372664 -
Oncol Lett
2017 Dec;14(6):6863-6868. PMID: 29344123 -
Hematology
Raloxifene inhibits the proliferation of pediatric acute myeloid leukemia by targeting the ANP32B gene and regulating C-MYC expression. [Abstract]2026 Dec 31;31(1):2691533. PMID: 42372253 -
World Neurosurg
Glycyrrhizic Acid Attenuates the Inflammatory Response After Spinal Cord Injury by Inhibiting High Mobility Group Box-1 Protein Through the p38/Jun N-Terminal Kinase Signaling Pathway. [Abstract]2022 Feb:158:e856-e864. PMID: 34838764 -
-
medRxiv
A liver-heart endocrine axis revealed by systems genetics and mediated by hepatocyte growth factor activator. [Abstract]2026 May 6:2026.05.05.26352474. PMID: 42145616 -
-
bioRxiv
Zuranolone mitigates delirium-like bispectral EEG changes, behavioral deficits, and neuroinflammation across surgical and inflammatory mouse models and age groups. [Abstract]2026 May 21:2026.05.19.726175. PMID: 42239266 -
bioRxiv
Serial Thermal Ablation Induces Abscopal Antitumor Immunity and Reveals Targetable CSF1R-Dependent Resistance in Pancreatic Cancer. [Abstract]2026 Apr 8:2026.04.05.713683. PMID: 41993287 -
bioRxiv
Circuit-selective cognitive vulnerability to environmental stress: multi-domain assessment of space radiation in both sexes reveals countermeasure trade-offs. [Abstract]2026 Mar 30:2026.03.26.714605. PMID: 41959325 -
-
-
-
bioRxiv
2025 Sep 3:2025.08.30.673282. PMID: 40949948 -
-
bioRxiv
Oncogenic and tumor-suppressive forces converge on a progenitor-orchestrated niche to shape early tumorigenesis. [Abstract]2025 Jun 12:2025.06.10.656791. PMID: 40661354 -
-
-
-
-
-
-
bioRxiv
2024 Jun 28:2024.06.23.600305. PMID: 38979280 -
-
bioRxiv
RBM39 degrader invigorates natural killer cells to eradicate neuroblastoma despite cancer cell plasticity. [Abstract]2024 Mar 25:2024.03.21.586157. PMID: 38585889 -
Res Sq
Dual activity of Minnelide chemosensitize basal/triple negative breast cancer stem cells and reprograms immunosuppressive tumor microenvironment. [Abstract]2024 Feb 22:rs.3.rs-3959342. PMID: 38464167 -
bioRxiv
2023 Oct 1:2023.09.29.560194. PMID: 37808711 -
-
bioRxiv
CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia. [Abstract]2023 Sep 16:2023.09.15.554413. PMID: 37745444 -
-
-
Oxid Med Cell Longev
Treatment with the Ferroptosis Inhibitor Ferrostatin-1 Attenuates Noise-Induced Hearing Loss by Suppressing Ferroptosis and Apoptosis. [Abstract]2022 Dec 7:2022:3373828. PMID: 36531206 -
-
-
-
-
-
-
-
-
-
Solvant et solubilité
In Vitro:
H2O : ≥ 100 mg/mL
* "≥" means soluble, but saturation unknown.
View the Complete Stock Solution Preparation Table
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Working solution concentration: 0.22 mg/mL
This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact
Protocole
Animal Administration[2]
Rats[2]
A 300 g rat is administered with 1 mL of a 0.1 M SBE-β-CD solution containing 5.64 mg of Compound 1, and assuming an extracellular volume of 90 mL, less than 0.1% of the complex would rapidly dissociate due to the initial effects of dilution. This calculation, combined with the changing blood to plasma ratio in the presence of SBE-β-CD, provides a reasonable explanation for the observed differences in the blood and plasma profiles of Compound 1 after intravenous administration in either the cyclodextrin or cyclodextrin-free formulations. After IV administration of the cyclodextrin formulation, Compound 1 would initially be prevented from distributing into erythrocytes thereby resulting in a whole blood to plasma ratio of less than one. Subsequently, clearance of SBE-β-CD from the circulation would lead to changes in the complexation equilibrium such that the unbound fraction of Compound 1 would increase, thereby reestablishing normal blood to plasma partitioning (i.e. in favour of whole blood) and clearance.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Pureté et documentation
Select Batch:
Pureté:
99.98%
Assay:
99.98%
ee.:
99.98%
-
Fiche technique (293 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Fukuda M, et al.Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion.Int J Pharm. 2008 Feb 28;350(1-2):188-196 [Content Brief]
[2]. Charman SA, et al. Alteration of the intravenous pharmacokinetics of a synthetic ozonide antimalarial in the presence of a modified cyclodextrin. J Pharm Sci. 2006 Feb;95(2):256-67 [Content Brief]
Calculators
Calculateur de molarité
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
=
×
×
Calculateur de dilution
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
SBE-β-CD Related Classifications
HY-17031 Related Classifications
Powered by Bioz